BRK.B vs INCY · rev $371.44B vs P/E 14, rev $5.14B
BRK.B (BRK.B) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
BRK.B currently screens at market cap $0. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the BRK.B and INCY stock pages for the full models.
Not investment advice.